Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains

Genome Research

Volumn 17, Issue 9, 2007, Pages 1319-1326

  Pravenec, Michal ^a   Hyakukoku, Masaya ^b,c   Houstek, Josef ^a   Zidek, Vaclav ^a   Landa, Vladimir ^a   Mlejnek, Petr ^a   Miksik, Ivan ^a   Dudová Mothejzikova, Kristyna ^a   Pecina, Petr ^a   Vrbacký, Marek ^a   Drahota, Zdenek ^a   Vojtiskova, Alena ^a   Mracek, Tomas ^a   Kazdova, Ludmila ^d   Oliyarnyk, Olena ^d   Wang, Jiaming ^c   Ho, Christopher ^c   Qi, Nathan ^e   Sugimoto, Ken ^f   Kurtz, Theodore ^c  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ANALYSIS; FEMALE; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; MITOCHONDRIAL GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; GENE DOSAGE; GENOME; HAPLOTYPES; MALE; MITOCHONDRIA; POLYMORPHISM, GENETIC; RATS; RATS, INBRED BN; RATS, INBRED SHR; RISK FACTORS; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

ANIMALIA; RATTUS;

EID: 34548412557     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.6548207     Document Type: Article

References (31)

1. Alcolado, J.C., Laji, K., and Gill-Randall, R. 2002. Maternal transmission of diabetes. Diabet. Med. 19: 89-98.
2. Asmann, Y.W., Stump, C.S., Short, K.R., Coenen-Schimke, J.M., Guo, Z., Bigelow, M.L., and Nair, K.S. 2006. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55: 3309-3319.
3. Behringer, R. 1998. Supersonic congenics? Nat. Genet. 18: 108.
4. Bustamante, E., Soper, J.W., and Pedersen, P.L. 1977. A high-yield preparative method for isolation of rat liver mitochondria. Anal. Biochem. 80: 401-408.
5. Calvo, S., Jain, M., Xie, X., Sheth, S.A., Chang, B., Goldberger, O.A., Spinazzola, A., Zeviani, M., Carr, S.A., and Mootha, V.K. 2006. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat. Genet. 38: 576-582.
6. Carelli, V., Giordano, C., and d'Amati, G. 2003. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 19: 257-262.
7. Fischel-Ghodsian, N. 2000. Homoplasmic mitochondrial DNA diseases as the paradigm to understand the tissue specificity and variable clinical severity of mitochondrial disorders. Mol. Genet. Metab. 71: 93-99.
8. Flachs, P., Novotny, J., Baumruk, F., Bardova, K., Bourova, L., Miksik, I., Sponarova, J., Svoboda, P., and Kopecky, J. 2002. Impaired noradrenaline-induced lipolysis in white fat of aP2-Ucp1 transgenic mice is associated with changes in G-protein levels. Biochem. J. 364: 369-376.
9. Fuku, N., Park, K.S., Yamada, Y., Nishigaki, Y., Cho, Y.M., Matsuo, H., Segawa, T., Watanabe, S., Kato, K., Yokoi, K., et al. 2007. Mitochondrial haplogroup N9a confers resistance against Type 2 diabetes in Asians. Am. J. Hum. Genet. 80: 407-415.
10. Galtier, N., Gouy, M., and Gautier, C. 1996. SEAVIEW and PHYLO_WIN: Two graphic tools for sequence alignment and molecular phylogeny. Comput. Appl. Biosci. 12: 543-548.
11. Gill-Randall, R.J., Adams, D., Ollerton, R.L., and Alcolado, J.C. 2004. Is human Type 2 diabetes maternally inherited? Insights from an animal model. Diabet. Med. 21: 759-762.
12. Jesina, P., Tesarova, M., Fornuskova, D., Vojtiskova, A., Pecina, P., Kaplanova, V., Hansikova, H., Zeman, J., and Houstek, J. 2004. Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206. Biochem. J. 383: 561-571.
13. Kren, V., Qi, N., Krenova, D., Zidek, V., Sladka, M., Mikova, B., Horky, K., Bonne, A., Van Lith, H., Van Zutphen, B., et al. 2001. Y chromosome transfer induces changes in blood pressure and blood lipids in SHR. Hypertension 37: 1147-1152.
14. Lowell, B.B. and Shulman, G.I. 2005. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387.
15. Maassen, J.A., Janssen, G.M., and Hart, L.M.T. 2005. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann. Med. 37: 213-221.
16. Mathews, C.E. and Berdanier, C.D. 1998. Noninsulin-dependent diabetes mellitus as a mitochondrial genomic disease. Proc. Soc. Exp. Biol. Med. 219: 97-108.
17. Mathews, C.E., McGraw, R.A., Dean, R., and Berdanier, C.D. 1999. Inheritance of a mitochondrial DNA defect and impaired glucose tolerance in BHE/Cdb rats. Diabetologia 42: 35-40.
18. Muller, P.Y., Janovjak, H., Miserez, A.R., and Dobbie, Z. 2002. Processing of gene expression data generated by quantitative real time RT-PCR. Biotechniques 32: 1372-1379. Erratum. 33: 514.
19. Nathan, D.M., Davidson, M.B., DeFronzo, R.A., Heine, R.J., Henry, R.R., Pratley, R., and Zinman, B. 2007. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 30: 753-759.
20. Petersen, K.F., Dufour, S., Befroy, D., Garcia, R., and Shulman, G.I. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350: 664-671.
21. Pravenec, M., Zidek, V., Simakova, M., Kren, V., Krenova, D., Horky, K., Jachymova, M., Mikova, B., Kazdova, L., Aitman, T.J., et al. 1999. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J. Clin. Invest. 103: 1651-1657.
22. Pravenec, M., Landa, V., Zidek, V., Musilova, A., Kren, V., Kazdova, L., Aitman, T.J., Glazier, A.M., Ibrahimi, A., Abumrad, N.A., et al. 2001. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27: 156-158.
23. Pravenec, M., Kazdova, L., Landa, V., Zidek, V., Mlejnek, P., Jansa, P., Wang, J., Qi, N., and Kurtz, T.W. 2003. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278: 45209-45215.
24. Rice, P., Longden, I., and Bleasby, A. 2000. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 16: 276-277.
25. Saxena, R., de Bakker, P.I., Singer, K., Mootha, V., Burtt, N., Hirschhorn, J.N., Gaudet, D., Isomaa, B., Daly, M.J., Groop, L., et al. 2006. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am. J. Hum. Genet. 79: 54-61.
26. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322: 223-228.
27. Silver, L. 1995. Mouse genetics: Concepts and applications. Oxford University Press, Oxford.
28. Sun, F., Cui, J., Gavras, H., and Schwartz, F. 2003. A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. Am. J. Hum. Genet. 72: 1515-1526.
29. Vrana, A., Poledne, R., Fabry, P., and Kazdova, L. 1978. Palmitate and glucose oxidation by diaphragm of rats with fructose-induced hypertriglyceridemia. Metabolism 27: 885-888.
30. Wallace, D.C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39: 359-407.
31. Wilson, F.H., Hariri, A., Farhi, A., Zhao, H., Petersen, K.F., Toka, H.R., Nelson-Williams, C., Raja, K.M., Kashgarian, M., Shulman, G.I., et al. 2004. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 306: 1190-1194.